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Abstract
Perfluorodecalin (PFD) is a chemically and biologically 
inert biomaterial and, as many perfluorocarbons, is also 
hydrophobic, radiopaque and has a high solute capacity for 
gases such as oxygen. In this article we have demonstrated, 
both in vitro and in vivo, that PFD may significantly 
enhance bone regeneration. Firstly, the potential benefit 
of PFD was demonstrated by prolonging the survival of 
bone marrow cells cultured in anaerobic conditions. These 
findings translated in vivo, where PFD incorporated into 
bone-marrow-loaded 3D-printed scaffolds substantially 
improved their capacity to regenerate bone. Secondly, in 
addition to biological applications, we have also shown 
that PFD improves the radiopacity of bone regeneration 
biomaterials, a key feature required for the visualisation 
of biomaterials during and after surgical implantation. 
Finally, we have shown how the extreme hydrophobicity of 
PFD enables the fabrication of highly cohesive self-setting 
injectable biomaterials for bone regeneration. In conclusion, 
perfluorocarbons would appear to be highly beneficial 
additives to a number of regenerative biomaterials, 
especially those for bone regeneration.
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Introduction
Bone repair and regeneration is highly dependent on 
the progeny of mesenchymal stem cells (MSCs) and 
their ability to affect healing at an injured site. Upon 
bone injury, bone marrow (BM) provides large numbers 
of MSCs that replicate and differentiate to lineages of 
mesenchymal tissues, including bone, and marrow stroma 
(Caplan, 1991; Pittenger et al., 1999; Jiang et al., 2002). 
Despite these properties, MSCs alone have proven to 
be unable to promote bone repair, and they require the 
support of a scaffolding biomaterial. Synthetic scaffolds 
allow cell migration, growth and differentiation into the 
site; however, they lack the biological activity of MSCs. 
Therefore, current research on bone healing focuses on 
seeding scaffolds with MSCs that will later help in the 
formation bone tissue (Bueno and Glowacki, 2009). 
Autologous bone marrow cells seeded into synthetic 
scaffolds have shown great potential in bone tissue 
engineering, and have been considered to be a potential 
candidate to replace autologous bone grafts as the material 
of choice for bone repair (Ohgushi et al., 1989; Goshima et 
al., 1991; Cheema et al., 2008; Meijer et al., 2008; Bueno 
and Glowacki, 2009; Kruyt et al., 2009).
  However, a major obstacle to this approach has been 
the survival of implanted cells (Meijer et al., 2008; Kruyt 
et al., 2009). In the short term, cellular survival depends 
on the availability of oxygen and nutrients, and also on 
the removal of metabolites. This process is facilitated 
by the vasculature, yet at implantation and during initial 
healing the blood supply in tissue-engineering scaffolds 
is compromised, which in turn causes local hypoxia and 
reduces cell vitality within implanted matrices (Cheema et 
al., 2008). One approach to alleviate this problem would 
be to provide a local oxygen source that would maintain 
cell viability until blood supply is restored. This concept 
has been evaluated for the regeneration of soft tissues by 
releasing oxygen from perfluorocarbons (PFCs) (Riess et 
al., 1988; Soman and Banerjee, 2003; Tan et al., 2009). 
PFCs are organic molecules where all hydrogen groups 
have been substituted with fluorine. These molecules are 
very stable, biologically inert and are easily eliminated 
by the body (Putyatina et al., 1994). PFCs have been 
found to dissolve high concentrations of oxygen that is 
released when the partial pressure of oxygen is reduced in 
the surrounding environment (Tan et al., 2009). For these 
reasons PFCs have been used in the biomedical field for 
many years as artificial vitreous replacements or synthetic 
oxygen carriers (artificial blood) (Riess et al., 1988; Riess 
and Krafft, 1998; Soman and Banerjee, 2003; Tan et al., 
2009). Perfluorodecalin (C10F18; PFD) is a particularly 
interesting PFC due to its high oxygen storage capacity, 
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and low vapour pressure, which renders it useful for oxygen 
delivery in the body (Riess et al., 1988; Riess and Krafft, 
1998; Roser et al., 1999; Soman and Banerjee, 2003; Tan et 
al., 2009). Its density (1.92 g/cm3) and viscosity (2.61 cS) 
are higher than water; therefore, it is a very useful liquid 
for the formulation of stable suspensions for injectable 
materials (Song-Ling and Maturo, 1975; Roser et al.,1999; 
Jeng et al., 2003). Moreover, PFD is radiopaque, and 
therefore has potential to act as a contrast agent for clinical 
radiologically guided procedures.
  Injectability is a pertinent topic in spine and 
maxillofacial surgery since it allows treatment via 
minimally invasive techniques. Bone cements are used as 
injectable biomaterials in different clinical applications, 
and set in vivo into hard functional materials (Gbureck 
et al., 2007a; Tamimi et al., 2009b). A cement paste 
consists of a suspension of solid particles in a liquid, and 
injectability of these materials is highly dependent on the 
stability of this suspension. Stable suspensions are best 
obtained when the liquid phase and the solid phase have 
a similar density. Improvements to the injectability of 
calcium phosphate cements (CPCs) have been achieved by 
increasing the amount of water in the cement, reducing the 
solid particle size and using additives such as hyaluronic 
acid and citrate ions (Barralet et al., 2004; Bohner et al., 
2006). Despite effective setting rate controllers being 
developed (Barralet et al., 2004), setting times still vary 
with ambient temperature and premixed set-on-injection 
cements are desirable to aid clinical application. Self-
setting premixed cements, based on glycerol, and other 
hydrophilic non-aqueous and non-toxic liquids, have been 
reported (Carey et al., 2005; Xu et al., 2007). However, the 
carrier liquid is inert and offers no additional biological or 
clinical functionality to the material.
  We hypothesised that PFD would considerably improve 
the physical and functional properties of calcium phosphate 
bioceramics for bone regeneration in two ways: firstly, 
by increasing radiopacity and injectability, and secondly, 
by improving their biological performance (i.e., oxygen 
delivery). Accordingly, in this study we investigated the 
effect of PFD on radiopacity, cohesion, and injectability 
of brushite cement, and the resulting cement was tested 
for in vitro and in vivo compatibility with living cells 
and tissues. Additionally, the effect of PFD gas storage 
capacity on bone marrow cells was investigated in vitro 
in cell cultures. Finally, the bone regeneration capacity of 
3D printed cement matrices loaded with PFD and BM cell 
was assessed in vivo in long-bone defects in rabbits.
Materials and Methods
The aim of this study was to determine the potential benefits 
of using PFD as a biomaterial for bone regeneration. The 
effect of PFD on the physical-chemical properties of 
injectable brushite cements was determined and we also 
investigated the effect of PFD on bone cells in vivo and 
in vitro, alone and in combination with brushite cement.
Preparation of PFD
PFD was purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Oxygen-loaded PFD (O2-PFD) was prepared by, 
bubbling the PFD with compressed air at a pressure of 
10 mbar for 15 min at room temperature (conditions shown 
to be optimal for saturating PFD with dissolved oxygen 
(Jewitt et al., 1999; Pilarek and Szewczyk, 2008)). The 
compressed air line was filtered by an indicating moisture 
trap and a hydrocarbon trap (Restek, Bellefonte, PA, USA). 
De-oxygenated PFC (N2-PFD) was prepared by bubbling 
pure N2 gas at a pressure of 10 mbar through PFD for 
15 min at room temperature (Jewitt et al., 1999; Pilarek 
and Szewczyk, 2008). PFD liquids were then sterilised 
by micro-filtration (0.22 μm filter, Millipore, Billerica, 
MA, USA).
Calcium phosphate cement combined with PFD 
(PFD-CPC)
Two types of cements were prepared in order to test the 
combination of PFD with calcium phosphate. A non-setting 
cement was prepared to assess injectability and radiopacity 
of the mixture, and a setting cement was fabricated to test 
the mechanical properties and setting time, as well as the 
in vitro and in vivo behaviour of the actual PFD-CPC. 
  Without additives, brushite cements set almost 
instantly upon contact with water, so in order to generate 
comparable data of injectability and radiopacity of cements 
premixed with PFD, a non-setting cement formulation was 
prepared (Bohner et al., 2006). The non-setting cement 
was composed of β-tricalcium phosphate (β-TCP) and a 
liquid (either PFD or distilled water). The β-TCP powder 
was prepared by heating a stoichiometric mixture of 
calcium carbonate and dicalcium phosphate dihydrate at 
900 °C for 14 h (Sigma-Aldrich) (Tamimi et al., 2009b). 
In order to assess the setting reaction of calcium phosphate 
cements premixed with PFD, a brushite cement powder 
was prepared from a homogeneous and equimolar mixture 
of monocalcium phosphate monohydrate (MCPM; ABCR, 
Karlsruhe, Germany) and β-TCP (1.00 g of MCPM for 
1.23 g of β-TCP) (Tamimi et al., 2009b). The different 
cement powder formulations (setting and non-setting) 
were premixed with PFD in a range of powder-to-liquid 
ratios (0.5-3.0 g/mL) to produce a stable cement paste 
(PFD-CPC) that set upon exposure to water (in case of 
the setting cements). Control cements were premixed 
with water instead of PFD. In order to stabilise the cement 
suspension in PFD, the cement powder was partially coated 
with magnesium stearate (MS) surfactant prior to mixing 
(Sigma-Aldrich). MS was dissolved in toluene (Fisher 
Scientific Company, Ottawa, ON, Canada) (1 % w/v), and 
the resulting solution was mixed with the CPC powder 
(1:1 = w:v). This process created a suspension that was 
left to dry at room temperature before the powders were 
flash heated to 80 °C until all toluene was eliminated. All 
in vitro and in vivo experiments using PFD-CPC were done 
with MS coated cement unless stated otherwise because 
the plain cement did not have sufficient injectability.
Radiopacity of PFD loaded cements
To evaluate the radiopacity of PFD containing bioceramics, 
200 mg of the non-setting cement powder was mixed with 
either water or PFD in different P:L ratios (0.5-2.0 g/mL) 
and placed in a flat bottom glass test tube (1.17 cm ø). The 
radiopacity experiments were designed to show the effect 24 www.ecmjournal.org
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of PFD on calcium phosphate radiopacity, for this reason 
we assessed the radiopacity in cement formulations ranging 
from no liquid phase at all (P:L = 1:0[∞]) to a powder-to-
liquid ratio of 0.5.
  The samples were analysed with an X-ray densitometer 
(Lunar Piximius II, GE Medical Systems, Bedford, UK). 
Levels of radiopacity were given in units of Bone Mineral 
Density (BMD; g/cm2) and radiographs were taken with 
an X-ray camera (Faxitron MX-20 , Faxitron X-ray Corp, 
Wheeling, IL, USA) in triplicate. BMD values were 
compared with expected values for comparable amounts 
of bone mineral (200 mg). Each formulation was prepared 
and tested in triplicate.
Injectability of PFD loaded cements
Two types of non-setting brushite cement powder were 
tested: pure β-TCP, or MS-coated β-TCP. The non-setting 
cement powder (500 mg; with or without MS coating) 
was mixed with PFD or water at different P:L ratios (1.0-
3.0 g/mL) and loaded in a 3 mL hypodermic syringe (BD, 
Franklin Lakes, NJ, USA). The syringes were adapted to 
fit a mechanical testing machine (Instron 5569; Instron, 
Canton, MA, USA), and an extrusion force was exercised 
at a constant velocity up to 15 mm/min. The experiments 
were stopped at a maximum force of 150 N. The volume 
of extruded cement was measured and the cement 
injectability percentage was calculated by dividing the 
volume of extrude cement by the original volume of cement 
loaded in the syringe (Barralet et al., 2004). Triplicate 
measurements were performed for each specific sample 
condition. Injectability experiments were designed to test 
the effect of PFD on the most challenging conditions (high 
P:L ratios). Therefore; we only show data on cements 
with high powder-to-liquid ratios (1.0-3.0). All cement 
formulations with low powder-to-liquid ratio (P:L <1.0) 
had a comparable very high injectability (>80 %) in our 
experimental conditions.
Setting reaction of PFD loaded cements
Self-setting cement powder coated with MS was premixed 
with either PFD or water at a P:L of 3.0 g/mL. The cement 
paste was injected into moulds (12 mm x 6 mm ø) and 
placed under water at 37 °C. Setting time was measured 
with Gilmour needles, and the cements were tested for 
compressive strength and X-ray diffraction (XRD) after 
24 h of incubation (Carey et al., 2005). Compressive 
strength of the cylindrical samples was measured with a 
universal testing machine (Instron® 5569, Norwood, MA) 
at a crosshead speed of 0.1 mm/min. X-ray diffraction 
patterns of the ground cements were collected using a 
vertical-goniometer X-ray diffractometer (Philips model 
PW1710, Philips, Eindhoven, The Netherlands), equipped 
with a Cu Kα radiation source. Data were collected from 5° 
to 55° with a step size of 0.02° and a normalised count time 
of 1 s per step. Phase composition was examined by means 
of the International Centre for Diffraction Data (ICDD) 
reference patterns for β-TCP (PDF Ref. 09-0169), monetite 
(PDF Ref. 09-0080), hydroxyapatite (PDF Ref. 09-0432) 
and brushite (PDF Ref. 09-0077). The mechanism of the 
setting reaction of the cement system was investigated 
by Fourier Transform Infrared Spectroscopy (FTIR) 
(Spectrum System BX400-650; Perkin Elmer, Waltham, 
MA, USA) using a single bounce ZnSe diamond-coated 
ATR crystal. Spectra were recorded between 4000 and 
350 cm-1 with a resolution of 4 cm-1, and 64 scans per run.
In vitro evaluation of bone marrow cells growth in the 
presence of PFD
In order to assess the potential benefits of PFD as an O2 
delivery agent into bone regeneration sites we designed 
a series of experiments in which we evaluated BM cell 
survival in hypoxic conditions when PFD is added. 
According to our hypothesis, we expected to observe 
increased cellular survival rates when PFD was added 
to hypoxic cell culture. All studies involving animals 
or animal tissues were performed in accordance with 
the McGill University guidelines established by the 
Canadian Council on Animal Care. The effect of N2-PFD 
(deoxygenated), O2-PFD and PFD-CPC (oxygenated), on 
BM cell proliferation and differentiation was evaluated in 
cell cultures derived from mouse BM. Mice (C57BL6/J, 
male, 6 weeks old) were purchased from Charles River 
(Charles River Co., Wilmington, MA, USA) and BM cells 
were collected from mouse tibia and femora as described 
previously in the literature (Armstrong et al., 2009). 
Briefly, femora and tibia were dissected under sterile 
conditions and the surrounding muscles were detached 
from the bones. Tibia and femora were cut in half and the 
bone marrow was flushed with minimum essential medium 
(MEM), containing 10 % serum and 1 % antibiotics 
dispensed by a 10 mL syringe with a 26-gauge needle. 
BM was flushed from the tibia and femora under aseptic 
conditions. Mouse-derived BM cells were then cultured in 
75 cm2 tissue culture flasks (2.5 x 106 cells/cm2) in MEM 
Label Whole medium n cells  N2-PFD O2-PFD Well sealed
US-WM 2.0 mL n/a n/a n/a No
US-cells “ 1.5·105   n/a n/a “
US-cells-PFD-N2 “ “ 400 µL n/a “
US-cells-PFD-O2 “ “ n/a 400 µL “
S-WM “ n/a n/a n/a Yes
S-cells “ 1.5·105  n/a n/a “
S-cells-PFD-N2 “ “ 400 µL n/a “
S-cells-PFD-O2 “ “ n/a 400 µL “
Table 1. Test conditions for in vitro incubation of mouse bone marrow stromal cells.
n/a: not applicable. S: sealed wells; US: unsealed wells; WM: whole medium without cells.25 www.ecmjournal.org
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with 10 % foetal bovine serum, 1 % antibiotics, 1 % sodium 
pyruvate and 50 µg/mL of ascorbic acid (Sigma-Aldrich 
Canada, Oakville, ON, Canada). After 5 to 7 days, cells 
were detached with trypsin/EDTA and plated at a density 
of 5 × 103 cells/cm2 in 48 well plates, onto the cell culture 
plastic for further experiments (Table 1).
  In order to evaluate the effect of O2 release from PFD 
on BM cells survival, an experiment was designed in which 
cell culture wells were filled with each one of the conditions 
described in Table 1. The different PFD liquids added were 
mixed thoroughly with the medium. The exposure of the 
cell culture medium to atmospheric O2 was controlled 
by either keeping them unsealed (open to gas exchange 
with the surrounding atmosphere), or sealed from the 
incubator atmosphere. The wells were sealed with cover 
slips and paraffin, and only opened for final analysis. After 
predetermined time points (0, 1, 3, 7, 14 and 21 days), the 
culture wells were opened for immediate O2 measurement 
with an oxygen electrode (MI-730; Microelectrodes Inc., 
Bedford, NH, USA), MTT and fluorometric DNA assays 
for cell counting. Each sample time point and assay was 
performed in triplicate on an independent set of samples. 
No repeated measurements were done, in order to reduce 
the risk of oxygen contamination from the atmosphere of 
the samples upon analysis.
  In order to assess activity of cellular enzymes with 
the MTT assay, culture medium was removed from the 
samples and 1 mL of 0.25 mg/mL MTT (Thiazolyl Blue 
Tetrazolium Bromide, Sigma M5655, Sigma-Aldrich) 
(prepared with cell culture medium) was added to each 
well (Carmichael et al., 1987). After 2.5 h of incubation 
at 37 °C, all MTT solution was removed and 1 mL DMSO 
was added to dissolve the formazan crystals. After 10 min 
of shaking, 200 μL of DMSO solution from each well 
was added to 96-well plates to measure absorbance at 
562 nm (EL800 Universal microplate reader, Bio-Tek 
Instruments, Winooski, VT, USA) (Carmichael et al., 
1987). The absorbance per cell was obtained by dividing 
the absorbance by cell number resulting from Hoechst 
33258 fluorometric DNA assay (see below), giving a 
normalised indicator of metabolic activity.
  In order to perform the Hoechst 33258 fluorometric 
DNA assay, cell medium was removed by overturning 
plates onto paper towels and stored at -80 °C. After thawing, 
400 μL of distilled water was added and incubated at 37 °C 
for 1 h. 400 μL of 40 μg/mL Hoechst 33258 (Invitrogen/
Life Technologies, Paisley, UK; H3569) in TNE buffer 
(10 mM Tris, 1 mM EDTA, 2 M NaCl, pH 7.4) was added to 
each well. Fluorescence was measured (excitation 346 nm, 
emission 460 nm) using SpectraMax M2e Multimode Plate 
Reader (Molecular Devices, Sunnyvale, CA, USA). Cell 
number standard curve was obtained by the fluorescence 
measurement of the serial dilutions of cells in wells (Rago 
et al., 1990; Otto, 2005).
In vitro injection of PFD-CPC
All in vivo and in vitro assessment of the cements were 
performed on the MS-coated formulations in order to 
provide the adequate injectability. The biocompatibility 
of PFD-CPC was compared with that of CPC, by directly 
injecting 200 μL of each cement mixture (P:L = 1.0) into 
separate cell culture wells previously seeded with bone 
marrow cells – as described earlier and with 2.0 mL of 
whole medium (we selected a cement formulation with 
a relative high PFD content, low P:L, in order to assess 
better the effect of PFD on the cells). Brushite cement is 
initially acidic, therefore in order to prevent immediate cell 
death during setting, the culture medium was refreshed 
whenever the pH dropped below 6.8, as many times as 
needed, in order to maintain pH neutrality. Afterwards, 
the cell cultures were incubated for different time points 
up to 21 days, and cells were counted at each time point 
(as described earlier).
  The biocompatibility of the cements could only be 
assessed in normoxic conditions (unsealed containers). 
This was because cells incubated with self-setting cements 
(CPC and PFD-CPC) in hypoxic conditions (sealed 
containers) died completely within 1 h, due to the rapid 
decrease in pH caused by the setting reaction of the cements 
when the medium is not refreshing (data not shown).
In vivo injection of PFD-CPC
In order to evaluate the in vivo behaviour of the new 
cement system, approximately 0.5 mL of premixed 
PFD-CPC (P:L = 2.5) was subcutaneously injected in 
the interscapular area through a 16G needle in 3 Balb-C 
mice. The interscapular area is very mobile, and excess 
movement could result in early disintegration of the 
cement before complete setting. For this reason, we 
selected a cement formulation with high powder to liquid 
ratio (2.5) that is less flowable and therefore more likely 
to remain stable after injection. Five days after injection, 
the animals were sacrificed and the samples were retrieved 
and fixed in paraformaldehyde. The cement was dissected 
from the tissue which was dehydrated, paraffin embedded 
and sectioned for histological evaluation. The cement 
composition was assessed with FTIR and XRD.
In vivo implantation of PFD loaded bioceramics
In order to obtain an accurate evaluation of the in vivo 
performance of CPC loaded with PFD in vivo, we assessed 
its effect in bone defects treated with prefabricated CPC 
implants.
  The geometry of the rabbit ulna bone was studied, 
and a computer-generated design of the rabbit distal ulna 
diaphysis was prepared (Fig. 1A). Tubular brushite ceramic 
blocks were 3D-printed as per the computer design (Fig. 
1B-C), following a previously reported technique for 
cement printing (Gbureck et al., 2007a).
  A total of 8 New Zealand rabbits (12 weeks old) were 
anaesthetised and incisions were made in the forearms to 
expose the ulna bone. A 1 cm long bone defect was created 
in each ulna after removing the periosteum from the site 
(Fig. 1D-G). In four rabbits, the defects were filled with 
the 3D-printed implants without any additive (negative 
controls; n = 8). In the other 4 rabbits, the marrow of 
the removed bone segment was collected, and prior to 
implantation, the inner chambers of the 3D-printed ceramics 
were loaded with 100 μL of BM retrieved from the surgical 
sites. BM is an autologous source of mesenchymal stem 
cells that is commonly used for improving bone healing 
outcomes (Connolly, 1995). Moreover, previous studies 26 www.ecmjournal.org
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have demonstrated the presence of abundant numbers of 
MSCs in the BM of young rabbits, such as the ones used 
in this study (Huibregtse et al., 2003). Upon implantation 
into the ulna defects, 100 μL of O2-PFD were added to 
the chamber of one of the implants (the experimental site; 
n = 4) whereas the contralateral implants were loaded with 
100 μL saline solution (positive controls; n = 4).
  The implants were secured in the defect using surgical 
wire, and the wound was closed through layered suturing. 
The animals were left to heal for 2 weeks prior to euthanasia. 
Retrieved explants were fixed in formalin for 24 h, washed 
in PBS and dehydrated in ascending concentrations of 
ethanol before embedding in polymethylmethacrylate 
resin (Heraeus Kulzer, Wehrheim, Germany). Longitudinal 
sections were cut using a Leica 1600 microtome saw 
(Leica, Bensheim, Germany) and stained with basic 
fuchsin and methylene blue for histological evaluation and 
histomorphometrical analysis.
  Histomorphometrical measurements were performed 
on digital optical micrographs of the sections using the 
software ImageJ (NIH, Bethesda, MD, USA). Due to the 
difficulties in quantifying the exact area of the implants in 
contact with bone (since values are sensitive to the imaging 
technique and the magnification at which they are taken), 
we measured the outer perimeter of the implant covered 
by bone (not necessarily in direct contact), and total 
external perimeter. These values were used to calculate 
the percentage of the outer perimeter that were covered 
by bone. The relative area of soft tissue present inside the 
implant hollow cavity was obtained by measuring the area 
of soft tissue inside the implant and dividing it by the total 
area.
Statistical analysis
All data are presented as mean values ± standard deviation. 
Statistical analysis was performed using SPSS software 
(SPSS for Windows version 12.0, SPSS Inc., Chicago, 
IL, USA). Data sets were assessed for normality using 
the Kolmogorov-Smirnov test. Sets passing the normality 
test were assessed using parametric techniques (One-Way 
ANOVA and Tukey post-hoc tests); non-normal sets were 
assessed using nonparametric techniques (Kruskal-Wallis 
One-Way Analysis of Variance on Ranks). Significance 
was set at a value of p < 0.05.
Results
Injectability, radiopacity, cohesion and mechanical 
properties of cements with PFD
PFD did not appear to affect the visual appearance of the 
non-setting cements (Fig. 2A). All non-setting cements had 
some degree of radiopacity; however, X-ray radiographs 
revealed significant differences in radio-opacity between 
non-setting cements with PFD, and with water (Fig. 2B). 
The BMD of the non-setting cements premixed with PFD 
was significantly higher (20-30 %) than those prepared with 
distilled water only (Fig. 2C). Increasing the amount of 
PFD in the formulation increased the radiopacity in a dose 
dependant manner, whereas increasing the amount of water 
Fig. 1. (A) Computer generated design for a 3D printed bioceramic implant. (B,C)  Brushite bioceramic printed as 
in the design in A. (D-G) surgical implantation of the 3D printed bioceramic in an ulna defect.27 www.ecmjournal.org
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Fig. 2. (A,B) Photograph (B) and X-ray radiograph (C) of 3 test tubes filled with: water (Control),  non-setting 
cement mixed with water (W), non-setting cement mixed with PFD (PFD) (P:L = 1.0 g/mL), and a rabbit ulna section 
for comparison  (Bone) (see Fig.1 D-E). (C) Effect of premixing with PFD on radiopacity of non-setting cement 
measured as BMD (g/cm2); the dashed line represents the BMD of a weight of bone comparable to the weight of 
the non-setting cement tested.
Fig. 3. (A) Graph depicting the injectability of non-setting cement premixed with water (W) or PFD (PFD), as well 
as the injectability of the non-setting cement coated with magnesium stearate (MS-coated) premixed with PFD. 
Injectability values are presented as a function of the powder-to-liquid ratio for each cement formulation. (B) Setting 
time, upon incubation in water, setting cement premixed with water (W) or PFD (PFD), as well as MS-coated setting 
cement premixed with PFD;* indicates significant differences between groups (p < 0.05). (C) Series of photographs 
of MS-coated setting cement premixed with PFD (P:L of 2.0 g/mL) showing (from left to right) injection into water, 
settling  and final setting.28 www.ecmjournal.org
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had no effect on the radiopacity of the non-setting cement. 
The degree of radiopacity of the non-setting cement 
premixed with water was very similar to that of normal 
bone mineral, whereas cements premixed with PFD were 
significantly more radiopaque than bone. These results 
indicate that adding PFD to calcium phosphate cements 
can help distinguish them from bone in a radiograph.
  The non-setting cement (pure β-TCP powder) mixed 
with water had poor injectability. Pure β-TCP could be 
premixed with PFD but the resulting formulation was 
only slightly injectable. However, the non-setting cement 
containing magnesium stearate was easily premixed with 
PFD resulting in a highly injectable formulation (Fig. 3A). 
The β-TCP powder coated with magnesium stearate could 
not be mixed with water due to its high hydrophobicity. 
Therefore, no cement could be prepared with this 
formulation. The P:L ratio of the different non-setting 
cements was inversely proportional to their injectability. 
However, the non-setting cements containing MS and PFD 
maintained a high degree of injectability even at high P:L 
ratios.
  The setting cement powder set within 2 min after 
mixing with water. Setting cements premixed with PFD 
only set after injecting them into water, which occurred 
within a clinically relevant period of time (~10 min), 
confirming that dissolution of PFD allowed the reaction 
of the cement with surrounding water, triggering the 
setting reaction (Fig. 3B, C). Once injected into water, 
the hydrophobicity of the PFD-premixed cement system 
prevented particle segregation, resulting in a high degree 
of cement cohesion (Fig. 3C). Also, the presence of PFD 
in the cement limited the initial reduction in pH caused 
by brushite cement setting reaction (Fig. 4). The mean 
compressive strength of the PFD-premixed cement (coated 
with MS), after storage in water (cement-to-water ratio = 
1:20) for 24 h at 37 ºC, was 2.3 ±1.3 MPa.
Biocompatibility of PFD-CPC in vitro and in vivo
In order to further test the biocompatibility PFD-CPC with 
bone cells in vitro, the CPC and PFD-CPC and PFD were 
incubated with BM cells. The cultured cells were tested for 
both vitality and capacity to differentiate. In the unsealed 
conditions, all BM cells implanted next to a water-mixed 
brushite CPC died within one day, while the cells incubated 
with PFD-CPC survived and proliferated for periods over 
20 days – giving results similar to cement free controls (Fig. 
5). Optical micrographs revealed that cell culture media 
incubated with CPC contained a large amount of loose 
particles, which were released from the setting cement (not 
shown), when compared to the culture medium of samples 
with PFD-CPC. This seemed to indicate an increase in 
cement cohesion as a result of adding PFD in the system, 
which was in agreement with injectability experiments.
  The PFD-CPC setting reaction was evaluated in vivo 
by injecting the cement preparation subcutaneously in 
a murine model. Upon ex vivo examination, the cement 
was observed to have set to form brushite, PFD had been 
eliminated, and histological analysis revealed no signs of 
inflammatory response (Fig. 6).
  The effect of PFD on BMSC survival in hypoxic culture
The effect of PFD on O2 partial pressure in cell culture 
media is shown in Fig. 7A. As might be anticipated, the 
concentration of oxygen in cell culture media was stable in 
the absence of cells, regardless of whether the containers 
were sealed (S-WM) or unsealed (US-WM). However, in 
the presence of cells, the concentration of O2 decreased 
over time, and this was more pronounced under sealed 
conditions.
  Both N2-loaded PFD and O2-loaded PFD had a similar 
effect on O2 levels in sealed cell culture media. Adding 
N2-loaded PFD to the sealed cell culture medium had little 
effect on the O2 concentration (S-cells-PFD-N2), compared 
to the sealed containers without PFD (S-cells) (Fig. 7A). 
O2-loaded PFD increased the O2 concentration at day 3 
(S-cells-PFD-O2, p < 0.05) compared to the other cell 
culture samples. However, O2 levels then rapidly dropped 
and by day 7 they were not significantly different from 
those measured in samples without PFD (S-cells) (Fig. 
7A).
  Cell survival was influenced by the availability of 
oxygen in the medium (Fig. 7B). For example, cells in 
unsealed samples (US-cells) survived longer than those in 
sealed wells (S-cells). Even though the presence of PFD 
caused an initial sharp decrease in cell numbers during 
Fig. 4. Evolution of the pH of the cement incubation 
medium as a function of time. The graph shows the 
results of the regular brushite cement (CPC), and brushite 
cement mixed with PFD (CPC-PFD).
Fig. 5. Graph showing bone marrow cell survival over 
time in unsealed culture medium (control), unsealed 
culture medium with brushite cement (CPC) or unsealed 
culture medium with PFD-loaded cement (PFD-CPC).29 www.ecmjournal.org
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the first days, cells in sealed wells survived longer when 
PFD was added. Throughout the experiment, a comparable 
number of cells were counted in both the N2-PFD and the 
O2-PFD cell culture samples.
  Metabolic activity of the different cell culture conditions 
as a function of time was assessed using the MTT assay 
(Fig. 7C). Cells cultured with PFD, both O2 and N2 loaded, 
showed much lower metabolic activity than those without 
PFD during the first 3 days (p < 0.05). However, after day 
7 metabolic activity in cells cultured with PFD increased 
dramatically, and was higher than in the cells without PFD 
(S-cells) (p < 0.05). US-cells presented a higher overall 
metabolic activity throughout the experiment.
  In order to assess more accurately the metabolic activity, 
MTT values were normalised for cell number (Fig. 7D). In 
all conditions the cellular metabolic activity appeared to 
increase as a function of time, probably due to the decrease 
in cell numbers over time. However, during the first 3 days, 
cells cultured in PFD, both O2 and N2 loaded, had lower 
normalised metabolic activity than those cultured without 
PFD. After day 7, the normalised metabolic activity of 
cells cultured in PFD and normalised metabolic activities 
became insignificantly different between all the hypoxic 
(sealed) cultures through the remaining time points of the 
experiment.
  Following implant explantation, qualitative surgical 
examination revealed that all the implants loaded with 
bone marrow (both PFD-loaded and saline-loaded) were 
firmly integrated with hard tissue growing on their external 
surface, whereas the control implants without BM appeared 
to be poorly integrated with the surrounding bone and 
covered with fibrous tissue. However, no quantitative 
Fig. 6. (A) Histological micrograph of cement injected subcutaneously in mice showing the set cement (*), and the 
connective tissue surrounding the implant (arrow). (B) X-ray diffraction pattern of the implanted cement, brushite 
intensity peaks (b) reveal that the material had reacted after implantation. (C) FTIR spectra of the cement prior and 
after implantation confirm that the cement has reacted after implantation showing that it is fully reacted to brushite. 
Monocalcium phosphate peaks characteristic of the unset brushite cement were detected in the cement formulation 
before implantation. PO2 peaks at 1158, 1120 and 1092 as well as P(OH)2 peaks at 975, 962, 914 and 888 indicated the 
presence of unreacted monocalcium phosphate while the strong bands at 1180-1310 are associated to the presence of 
PFD. Peaks associated with brushite were observed in the cement after implantation. OH peaks associated with DCPD 
formation appeared as expected at 3550, 3465, 3255, 3160 and 1640 cm-1 on top of the broad ‘‘free’’ water bands. 
Additional sharp PO peaks developed at 1110, 1050, 980 and 860 cm-1, consistent with dicalcium phosphate. No PFD 
related bands were detected after implantation, indicating that the organic solvent has been eliminated from the site.30 www.ecmjournal.org
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analysis was performed to assess these macroscopic 
differences between the explants. Histological examination 
confirmed that bone tissue had formed only on the external 
surface of the 3D-printed ceramics, while the marrow 
cavity of the ceramics had only soft tissue growing inside 
(Fig. 8A-F, Fig. 9). Interestingly, BS-SEM images revealed 
that the outer perimeter of the implants loaded with PFD 
were more irregular than the ones loaded not loaded with 
PFD, and often presented a gap between the new bone and 
the implant (Fig. 9).
  Histomorphometric analysis of the 3D printed 
bioceramics revealed that soft tissue growth in the marrow 
of the implant was highest in implants loaded with BM 
and PFD (p < 0.05), followed by implants loaded with 
BM alone, and implants without BM (control) (Fig. 8). 
Similarly, bone growth on the external cortical surface of 
the implant was more extensive in the implants loaded with 
BM and PFD (p < 0.05), followed by implants loaded with 
BM alone, while implants with neither cells nor PFD had 
the least bone growth on their surface (Fig. 8).
Discussion
Physico-chemical properties of premixed CPC
Calcium phosphate cements suffer from several practical 
drawbacks which limit their clinical application, firstly they 
need to be mixed in theatre and secondly, despite having the 
capacity to be injectable (Barralet et al., 2004), they are by 
themselves insufficiently radio-opaque for fluoroscopically 
guided procedures (Chen et al., 2010). Self-setting CPCs 
have recently been developed by substituting the cement 
liquid phase with biologically inert, viscous, non-aqueous 
liquids such as glycerol and polyethylene glycol to deliver 
the cement reactants through a nozzle (Carey et al., 2005; 
Xu et al., 2007). The absence of water in these formulations 
enables the pre-mixed pastes to be stored in a ready-to-use 
form, and upon injection in vivo, the diffusion of water into 
the paste enables setting. Similarly, in our study, the use 
of PFD enable the preparation of injectable self-setting 
cements comparable to those previously prepared with 
glycerol or poly (ethylene) glycol.
  Most inorganic bone regeneration biomaterials are 
difficult to distinguish from the native bone and usually 
insoluble barium and strontium salts are added to improve 
radiopacity (Alkhraisat et al., 2008; Yu et al., 2009). 
However, these additives serve no biological function and 
remain in the patient after application, additionally they can 
alter the rheology and other physical properties of CPCs 
(Alkhraisat et al., 2008). PFD is known to be radiopaque, 
and its fluorine groups are easily detected by magnetic 
resonance imaging (McFarland et al., 1985). In this proof 
of concept study we demonstrated significant improvement 
in radiopacity when PFD is included in a CPC formulation. 
Fig. 7. (A) Atmospheric partial pressure of O2 in different cell culture media as a function of time. (B) Cell count as 
a function of time in different cell culture media. (C) Metabolic activity as a function of time. (D) Metabolic activity 
per cell number as a function of time. Figure labels are defined in Table 1.31 www.ecmjournal.org
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It should also be remembered that halogenated decalins 
such as PFD can be partially brominated, increasing their 
radiopacity even further with little change in toxicity and 
physical properties (Long et al., 1971; Long et al., 1975; 
Lowe, 1991; Mattrey et al., 1987; McFarland et al., 1985).
Oxygen delivery in vitro
Oxygen levels in bone surgical sites have been previously 
measured in osteotomised rabbit tibiae, and were initially 
found to be as low as 1.3 % (Kivisaari and Niinikoski, 1975; 
Aro et al., 1984). Therefore, early vascular regeneration 
is essential for the normal progress of fracture healing. 
Damaged blood vessels in a bone fracture require at least 2 
weeks to re-establish the original blood flow in the healing 
area (Kurdy et al., 1996). It also takes at least 4 weeks for 
O2 levels to recover to normal physiological levels (Aro et 
al., 1984; Kivisaari and Niinikoski, 1975; Grayson et al., 
2006; Grayson et al., 2007), although this response may 
vary depending on the specific charactersitics (size) of the 
bone fracture itself (Kurdy et al., 1996).
  Hypoxia has a well-documented effect on bone 
formation and resorption (Kivisaari and Niinikoski, 1975; 
Aro et al., 1984; Kurdy et al., 1996; Grayson et al., 2006; 
Grayson et al., 2007). Under physiological conditions, 
oxygen partial pressure in the BM is estimated to range 
from 2 % to 7 %. However, proliferation of MSCs is 
higher at atmospheric oxygen levels (21 %) than under 
physiological conditions (Grayson et al., 2006; Ma et 
al., 2009; Sengupta et al., 2010). A reduction in oxygen 
levels from 21 % to 1 % results in a reduction in cellular 
proliferation and adipogenic and osteogenic differentiation 
of human MSCs (Arnett et al., 2003; Knowles and 
Fig. 8. (A-I) Histological images showing implanted bioceramics alone (control), loaded with bone marrow (BM) 
from the same rabbit, and loaded with bone marrow combined with PFD (BM+PFD). (A-C) show the interface at 
the inner compartment of the cylinder (In) (original magnification x10; field of vision = 1.2 mm). (D-F) show the 
interface at the external (Ext) surface of the cylindrical bioceramics (original magnification x10; field of vision = 
1.2 mm). (G-I) are higher magnification of the area indicated with a white square in D-F respectively (original 
magnification x20; field of vision = 0.6 mm). The histological micrographs show the bioceramic (white star), the 
soft tissue growing inside the implant (+), the bone growing on the outer surface of the implant (double arrow), and 
the bone implant-interface (single arrow). All sections were stained with basic fuchsin/methylene blue. The scale bar 
length = 200 μm. (J) Histomorphometric analysis of the histological sections showing the percentage of the external 
surface of the implant that is covered with bone, and the volume of the inner part of the implant that is filled with 
soft tissue; * indicates significant differences between groups (p < 0.05). The white column represents the control 
samples, the light grey represents the samples loaded bone marrow cells, and the dark grey the samples loaded with 
bone marrow cells combined with PFD.32 www.ecmjournal.org
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Fig. 9. BS-SEM images (A and B) and light microscopy low magnification images (C and D) of the outer surface 
of the implants, as well as light microscopy low magnification images of the inner hollow part of the implants (E 
and F). A , C and E show implants loaded with bone marrow, while B, D and F show the implants loaded with bone 
marrow and PFD. *: bioceramics; white arrow: bone callous; black arrow: marrow tissue.
Athanasou, 2009; Holzwarth et al., 2010). BM aspirate, 
which is rich in MSCs, is often used to aid bone healing 
(Jiang et al., 2002) and so the ability to manipulate 
localised oxygen concentrations around a graft substitute 
is highly relevant to healing optimisation.
  In our in vitro experiments, unsealed cell free culture 
media maintained unaltered atmospheric levels of O2. 
Adding cells to the media resulted in a mild decrease in 
O2 partial pressure, reaching levels of 13 % by day 21, and 
a reduction in cell number over the same period, probably 
due to nutrient depletion since the culture medium was not 
replenished. On the other hand, O2 partial pressures were 
significantly lower in sealed cultures (4 % by day 21) and 
by day 21 all the cells had died. However, when incubated 
with PFD cell survival was significantly extended, although 
this effect was observed with both O2-PFD and N2-PFD. 
The quantity of PFD in a culture dish was 400 µL PFD 
(added to 2 mL media). This could have a maximum 
oxygen content of 278 µM in each well (of which PFD 
could have contributed 37 %, 104 µM) (Lane, 1995). 
Oxygen consumption by cells is estimated as being ~1 x 
10-7 µM∙s-1 per 103 cells, as reported previously on dermal 
fibroblasts (Brown et al., 2007). Therefore over the duration 
of our experiment, assuming a constant cell number of 1.5 
x 105, the oxygen demand could be estimated in the order 
of 150 x 10-7 x 3600 x 24 x 21 = 27 µM O2, i.e, an order of 
magnitude less than what was available. Clearly then, both 
theoretical considerations and the experimental observation 
that O2-free PFD also prolonged cell viability (Fig. 7B) 
indicate that additional oxygen supply from PFD was not 
a factor in prolonging cell survival in hypoxic conditions. 
Therefore, PFD could have been affecting cell survival 
through another mechanism such as reducing metabolic 
activity. To test the hypothesis that PFD may reduce cell 
metabolic activity, we measured metabolic activity using 
the MTT assay. Our results showed that the presence 
of PFD did cause a reduction of the cellular metabolic 
rate during the first days of cell culture, but by day 7 the 
metabolic activity was similar for all culture conditions 
(Fig. 7D). This possible effect on metabolism could be also 
the reason behind the initial drop in cell numbers observed 
in bone marrow cells cultured in the presence of PFD. 
However, we are not sure why PFD appeared to decrease 
cell metabolic activity. A possible explanation could be the 
change in microenvironment from an aqueous osmotically 
balanced and nutritionally sufficient media to PFD. It may 
take some hours for proteins and other essential small 
molecules and ions to diffuse through the PFD layer on 
top of the cells. Clearly more work is required to elucidate 
the mechanism.
  Carbon dioxide has a higher solubility in PFD than 
oxygen (Riess et al., 1988; Riess and Krafft, 1998; Soman 
and Banerjee, 2003; Tan et al., 2009), which is the basis 
for using PFD as artificial haemoglobin. Therefore, in 
sealed hypoxic conditions, it is likely that PFD was able 
to maintain gaseous homeostasis, which could have also 
caused the unexpectedly strong effect on cell survival, 
although future studies will have to be performed to clarify 
this possibility.
  CPC samples without PFD had a dramatic negative 
effect on BMSC survival (no viable cells were detectable 
after day 3, Fig. 5). CPC without PFD had poor cohesion 
and released a large amount of particles when injected 
into the medium. In contrast, it seems that the excellent 33 www.ecmjournal.org
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cohesion of PFD-CPC prevented the release of particles. 
Since the pH of the cell culture media was maintained at 
neutrality throughout both experimental conditions, it is 
possible that differences in cohesion could have caused the 
significant differences in cell survival between the water-
based CPC and the PFD-based CPC. Indeed particle release 
from biomaterials has been found to have a negative effect 
on cellular survival in the surrounding tissues (Lochner 
et al., 2011). However, the effect of particle release from 
cements on cellular survival needs further investigation.
Tissue engineering with 3D printed bioceramics 
loaded with BM and O2 loaded PFD
3D-printed CPCs offer a unique opportunity to treat 
complicated bone defects by designing the implant 
according to the specific required geometry (Gbureck 
et al., 2007a). In previous studies we have shown the 
osteconductive and osteoinductive potential of 3D printed 
CPCs on goat vertebrae (Habibovic et al., 2008), and we 
have also been able to augment craniofacial bones using 
this 3D printed materials (Tamimi et al., 2009a). However, 
this is the first study in which we report the repair of a 
large defect in a long bone using a 3D printed bioceramic. 
Unfortunately, 3D-printed brushite implants alone had a 
limited capacity to resolve the large bone defect in a short 
period, probably due to the size of the defect. However, 
combining the 3D-printed CPC with BM and PFD resulted 
in a significant increase in bone formation around the 
implant within 2 weeks, and the implanted synthetic 
material was well integrated with the native bone.
  Even though the number of mesenchymal stem cells 
in BM is limited, autologous BM has proven effectiveness 
for osteogenic stimulation in bone repair (Connolly et 
al., 1995). This could be the reason behind the increased 
soft and hard tissue formation around the implants loaded 
with BM compared to those without BM. Similarly to 
previous research, our study revealed that the combination 
of bioceramic implants with BM substantially increased 
the amount of bone growing on the outer implant surface 
(Kon et al., 2000; Marcacci et al., 2007). Interestingly, even 
though different amounts of bone grew on the outer surface 
of all the implants, no bone formation occurred within the 
inner compartment of any of the implants tested. In a very 
recent study, it was demonstrated that new bone formation 
in long bone defects originates solely from periosteal 
mesenchymal stem cells at the edges of the defect, and 
not from bone marrow cells (Grcevic et al., 2012). In 
our study, bone was creeping in from the outer edges of 
the defect, and on to the outer surface of the implants. 
The inner compartment of the cylindrical implants was 
partially isolated from the periosteum of the bone defects, 
and this could be the reason why we did not observe bone 
forming inside the cylindrical implants. In addition, due 
to the difference in accessibility to the tissues surrounding 
the implant, it is likely that the blood supply on the outer 
surface of the implant would be more abundant than in the 
inside. However, this issue will have to be investigated in 
future studies.
  The porosity of the 3D-printed brushite bioceramics 
used in this study was 26 %, with an average pore size 
of 12.3 μm (Gbureck et al., 2007b). This limited porosity 
is inadequate for cell migration through the walls of the 
bioceramics. However, it is enough to allow the movement 
of large molecules (Gbureck et al., 2007b). Therefore, 
the increase in bone formation on the outer surface of the 
implants loaded with BM may have been an indirect effect. 
MSCs secrete a broad range of bioactive molecules, such 
as growth factors, cytokines and chemokines (Caplan and 
Dennis, 2006; Meirelles et al., 2009). Accordingly, the 
higher amount of bone growth on the outer surface of 
the implants loaded with BM compared to the BM-free 
samples (p < 0.05), may have been caused by the trophic 
effect of the MSCs in the marrow tissue placed inside the 
implants. Although future studies will have to be performed 
in order to confirm this possibility.
  Based on previous studies we would expect an 
oxygen content of 1.3 % or lower (Aro et al., 1984) in 
the osteotomised ulna bone. This partial pressure of O2 is 
inadequate for osteogenesis, therefore the presence of PFD 
would be of interest in these specific conditions. Indeed, the 
bioceramics loaded with both BM and O2-PFD had more 
bone on the outer surface of the implant and more soft 
tissue in the inner part ceramic than the implants with BM 
alone. This result indicates that PFD might have benefited 
the survival of BM cells inside the implants, resulting in 
increased bone formation on the implant outer surface 
through the trophic effect of the bone marrow cells (Caplan 
and Dennis, 2006).
Future studies
In this study we have demonstrated that PFD increased the 
survival rate of BM cells under anaerobic condition, which 
translated to increased bone regeneration in vivo. These 
results show that combining stromal cells with PFD may 
be a viable approach for enhanced bone tissue engineering. 
However, future research will have to be done in order to 
fully understand how PFD prolongs cellular survival in 
hypoxic conditions.
  Another possible application that has not been explored 
in this work is the potential use of PFD cement as a delivery 
system for signalling gases such as NO, CO or H2S into 
bone regeneration sites. These new type of materials may 
improve bone cell survival and differentiation in tissue 
engineering procedures.
  BS-SEM observations revealed a gap between the 
mineralised tissues and the implants loaded with PFD. 
This gap could be due to two reasons: PFD could be having 
an inhibitory effect on mineralisation, or the implants 
are resorbing faster in the presence of PFD. In fact, BS-
SEM images revealed that the surface of implants loaded 
with PFD had more irregular surface outer surface than 
the PFD-free (an indication of higher resorption rate). 
However, our study was not designed to assess biomaterial 
resorption (due to the complex geometry of the implants) 
or osteoclast/macrophage activity (due to the absence of 
immune histochemistry markers), and future studies will 
have to be done in order to clarify whether or not PFD has 
any significant effect on biomaterial resorption in vivo and/
or mineralisation.34 www.ecmjournal.org
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Conclusions
In this study we have shown that anaerobic conditions have 
a negative effect on bone stromal cell survival. However, 
the presence of PFD into anaerobic culture media can 
prolong cell survival. The combination of PFD with a 
tissue engineering bioceramic increased the radiopacity, 
injectability and cohesion of bone cements. Additionally, 
the ability of bone-marrow-loaded bioceramics to 
regenerate bone is enhanced with the addition of PFD. 
We conclude that PFD might be a useful biomaterial in 
bone tissue engineering and warrants further investigation.
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Discussion with Reviewers
Reviewer I: Do you think that oxygen is being released 
from the PFD? If so, why was there no difference from 
the nitrogen-infused and the oxygen-infused samples? If 
not, why not?
Authors: We designed our study to assess whether or not 
PFD may be acting as a reservoir of Oxygen that releases 
gases until equilibrium is reached with the surrounding 
environment. However, our data indicate that O2 seems 
to be released very fast and equilibrium is reached fairly 
quickly during the first hours. That is why differences in O2 
release between the nitrogen-infused and oxygen-infused 
samples were negligible.